Form 4 for MGRX MANGOCEUTICALS, INC.
Accepted 2025-09-12 00:00:00 ET · period of report 2025-09-09 · accession 0001641172-25-027216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-12 | 2025-09-09 | MGRX | D'Alessio Lorraine Pamela | Dir | A - Grant | $0.00 | +100.0K | 136.7K | +273% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-09 | A | A | 100,000 | $0.00 | 136,667 | D | — | — | (F1) Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |